Drug diversion is a serious concern facing all healthcare institutions, and the VA is not immune to this problem. Since 2009, VA medical centers and other federal hospitals have seen a notable increase in opioid thefts, missing prescriptions, and unauthorized drug use by staff. Do you know how to proactively monitor for diversion in your government facility? Join diversion expert Kimberly New for guidance on establishing controls within your facility to effectively address drug diversion.
In this webinar, you will:
Understand the risks and consequences facilities face when they don’t have a drug diversion monitoring program in place
Discover best practices for preventing, detecting, and managing drug diversion within your VA facility, complying with VHA’s requirements
Learn about past drug diversion activity at facilities that lacked processes to effectively monitor for diversion
Register for this webinar to learn from the expertise of Kim New, who can guide your diversion prevention efforts.
Kimberly New, JD, BSN, RN
Kimberly New, JD, BSN, RN, is a specialist in controlled substance security and DEA regulatory compliance and consults with healthcare facilities across the country. She has made a career of assisting facilities develop and refine their drug diversion programs, with a goal of protecting patients from the harm that is frequently associated with diversion. She is the cofounder and Executive Director of the International Health Facility Diversion Association, and a member of the Executive Board of the Partnership for Safe Medicines.
You may register to view the webinar below.